Navigation Links
Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose
Date:6/11/2008

Data Presented as Poster Presentation at the Associated Professional Sleep

Societies 2008 Annual Meeting

BALTIMORE, June 11 /PRNewswire/ -- Data was presented today at the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS) demonstrating that within 20 minutes of administration, Intermezzo(R), an investigational low-dose, sublingual formulation of zolpidem, delivered overall bioavailability that was significantly greater than that produced by a swallowed Ambien(R) tablet containing a zolpidem dose that was nearly 3 times higher. Despite this higher initial bioavailability, zolpidem blood levels from sublingual 3.5 mg Intermezzo(R) were significantly lower four hours after administration than the levels produced by the 10 mg Ambien(R) dose. Transcept Pharmaceuticals is developing Intermezzo(R) for the treatment of insomnia characterized by middle-of-the-night (MOTN) awakenings with difficulty returning to sleep.

"One significant challenge in trying to help insomnia patients return to sleep after a middle-of-the-night awakening is that the most commonly prescribed bedtime medications are not designed to be taken as needed in the middle of the night without risking significant drowsiness the following day," said Thomas Roth, Ph.D., Chief of Sleep Medicine, Henry Ford Hospital Sleep Disorders and Research Center in Detroit and principal investigator in this study. "The only recourse to date for patients has been either to try to predict what nights they will awaken, or to take sleep medication every night at bedtime. Studies of Intermezzo(R) show promise in offering the first viable, 'use only when needed' option for treating awakenings in the middle of the night when they occur."

Intermezzo(R): Rapid bioavailability despite a lower dose

In the pharmacokinetic comparison study presented at APSS, 36 healthy subjects between the ages of 19 and 64 were randomized to receive either a 3.5 mg. Inte
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
2. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
3. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
4. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
5. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
6. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
7. Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
8. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
9. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
10. Bionomics Achieves US$1 Million Milestone Payment from Genmab
11. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... The 2009 Frost & Sullivan European ... is conferred on SonoScape. The award recipient has ... for special features, pricing, and portability - and ... performance of this high-end colour Doppler HCU compares ... ultrasound system. ,, (Logo: ...
(Date:12/14/2009)... Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ... Notice of Allowance from the United States Patent ... patent application no. 11/060,641, which covers the composition ... sublingual tablet), the lead Transcept product candidate. ... than February 2025. ,, "This is the second ...
(Date:12/14/2009)... BioTrends Research Group, Inc. released ChartTrends®: Biologics ... comprehensive insight into the management of RA patients. ... of self-reported treatment approaches (as reported by 208 ... 1,000 RA patients who are currently being treated ... the audit, patients had to currently be treated ...
Breaking Medicine Technology:Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 2Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 3Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 2Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 3Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 4New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 2New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis 3Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 1Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 2Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 3Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 4Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 5Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 6President Obama Misleads on Abortion Funding in Health Care Reform 54931 1President Obama Misleads on Abortion Funding in Health Care Reform 54931 2Kaiser Workers Launch Statewide Pickets 54929 1
(Date:12/14/2009)... Attitudes and Behavior Regarding Pregnancy, Contraception, and Related Issues ... all unmarried young adults ages 18-29 believe pregnancy is ... 86% of women) and say that it is important ... of men and 88% of women), according to new ... and Unplanned Pregnancy. Even so: ,, Only ...
(Date:12/14/2009)... In today,s academic medical centers, value ... Now the University HealthSystem Consortium (UHC) has created ... Achieving Cost Efficiencies in Health Care, to ... These new materials, developed with the input of ... practical guide to planning, implementing, and managing all ...
(Date:12/14/2009)... particles carry oxygen, drugs, and more… , ... ... Santa Barbara, in collaboration with scientists at University of Michigan, ... key functions of natural red blood cells, including softness, flexibility, ... , ,The primary function of natural red blood cells is ...
(Date:12/14/2009)... revolutionary new liposuction and fat transfer treatments can help people ... one minimally invasive treatment. , ... ... NaturalFill™ can remove excess fat from the abdomen and inject ... down, reduce facial wrinkling and enhance lips all in one ...
(Date:12/14/2009)... ANN ARBOR, Mich., Dec. 14 ... and the Commonwealth of Kentucky are among the ... solution this fall to help their employees make ... Enrollment solution gives employees a personalized summary of ... cost of that care. With this personalized information, ...
Breaking Medicine News(10 mins):Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 2Health News: Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling 3Health News:Corporations, Universities and State Governments Deploy Thomson Reuters Solution to Improve Employees' Benefit Selection Process 2
... Inc. the pioneer,of plasma skin regeneration and sole ... thermal energy called plasma for reversing the signs ... and Drug Administration (FDA),clearance to market a new ... cleared by the FDA for treating facial and ...
... Study finds pros more likely to take measures improving ... Trying to be the next American Idol could harm ... are less sensitive than their professional peers to the ... voice issues, according to new research published in the ...
... to a,bipartisan compromise brokered by Foreign Affairs Committee ... overwhelmingly to expand the,landmark U.S. effort to combat ... saved millions of lives., Despite efforts by ... it provides, the Tom Lantos and Henry J. ...
... Patients Rising, CHICAGO, April 2 Millions ... and, according to the latest research,from Prevent Blindness ... continuing to climb. With more than 130 million ... suffer from leading causes of vision loss such,as ...
... Action on the House Floor, WASHINGTON, April 2, ... Toomey, President and CEO, American Lung,Association:, The American ... Commerce Committee for its passage of the Family,Smoking Prevention ... full,House to quickly take action to move this life-saving ...
... weeks or more, it predicts major episodes, study finds ... of insomnia in young adults can increase their risk ... long-term study of almost 600 young adults found that ... incidents of sleeplessness gradually increased over two decades, especially ...
Other Medicine News:Health News:Portrait(R) Plasma Receives Clearance from the FDA to Treat Acne Scars 2Health News:Portrait(R) Plasma Receives Clearance from the FDA to Treat Acne Scars 3Health News:House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort 2Health News:House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort 3Health News:Eye Disease Continuing to Increase Among Americans 2Health News:Eye Disease Continuing to Increase Among Americans 3Health News:Persistent Insomnia Leads to Depression in Young Adults 2
Plastic Block Filing Cabinet is a durable, six-drawer unit that holds up to 1500 slides....
Shandon Laser MicroWriter is a laser labeling system developed specifically for anatomical pathology....
Scienceware® Slide Tray Cabinet holds twelve Scienceware® H44581 microscope trays horizontally in a dust free enclosure....
Fully modular system for long-term storage. Available as complete five-drawer system or as individual components....
Medicine Products: